Join
Live feed
·
INSIDERFilingvia Quantisnow
Paratek Pharmaceuticals Inc. logo

SEC Form 4: Bigham Michael was granted 143,182 shares and sold $76,174 worth of shares (28,637 units at $2.66) as part of a pre-agreed trading plan, increasing direct ownership by 10% to 1,207,827 units (tax withholding)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PRTK (Paratek Pharmaceuticals Inc.) and more on Quantisnow.